<!DOCTYPE html>
<html>
<head>
<style>
  table {
    width: 100%;
    border-collapse: collapse;
    font-family: Arial, sans-serif;
    font-size: 14px;
  }
  th {
    background-color: #f2f2f2;
    color: #333;
    font-weight: bold;
    text-align: left;
    padding: 10px;
    border-bottom: 2px solid #000;
  }
  td {
    padding: 8px 10px;
    border-bottom: 1px solid #ddd;
    vertical-align: top;
  }
  tr:hover {background-color: #f9f9f9;}
  .category-header {
    background-color: #e6e6e6;
    font-weight: bold;
    color: #000;
  }
</style>
</head>
<body>

<h2>Table 1: Baseline characteristics, clinical presentation, and outcomes comparing Lived vs Died groups</h2>

<table>
  <thead>
    <tr>
      <th>Variable</th>
      <th>Lived (N=97)</th>
      <th>Died (N=19)</th>
      <th>OR (95% CI)</th>
      <th>P-value</th>
    </tr>
  </thead>
  <tbody>
    <tr class="category-header"><td colspan="5">Demographics</td></tr>
    <tr><td>Age (years)</td><td>57.44 ± 19.75<br>Median: 59.00 (IQR: 31.00)</td><td>58.63 ± 16.53<br>Median: 57.00 (IQR: 21.50)</td><td>-</td><td>0.873</td></tr>
    <tr><td>Sex</td><td>Female: 49 (50.5%)<br>Male: 48 (49.5%)</td><td>Female: 12 (63.2%)<br>Male: 7 (36.8%)</td><td>0.60 (0.21-1.68)</td><td>0.315</td></tr>
    <tr><td>Race</td><td>Asian: 93 (95.9%)<br>Caucasian: 4 (4.1%)</td><td>Asian: 19 (100.0%)<br>Caucasian: 0 (0.0%)</td><td>0.00 (0.00-nan)</td><td>1.000</td></tr>
    <tr><td>Hypertension</td><td>No: 62 (63.9%)<br>Yes: 35 (36.1%)</td><td>No: 12 (63.2%)<br>Yes: 7 (36.8%)</td><td>1.03 (0.35-2.92)</td><td>1.000</td></tr>
    <tr><td>Dyslipidemia</td><td>No: 72 (74.2%)<br>Yes: 25 (25.8%)</td><td>No: 15 (78.9%)<br>Yes: 4 (21.1%)</td><td>0.77 (0.21-2.43)</td><td>0.778</td></tr>
    <tr><td>Diabetes Mellitus type2</td><td>No: 81 (83.5%)<br>Yes: 16 (16.5%)</td><td>No: 17 (89.5%)<br>Yes: 2 (10.5%)</td><td>0.59 (0.10-2.34)</td><td>0.733</td></tr>
    <tr><td>History of stroke</td><td>No: 92 (94.8%)<br>Yes: 5 (5.2%)</td><td>No: 17 (89.5%)<br>Yes: 2 (10.5%)</td><td>2.16 (0.32-11.41)</td><td>0.327</td></tr>
    <tr><td>Chronic kidney disease</td><td>No: 90 (92.8%)<br>Yes: 7 (7.2%)</td><td>No: 18 (94.7%)<br>Yes: 1 (5.3%)</td><td>0.71 (0.05-5.32)</td><td>1.000</td></tr>
    <tr><td>Coronary artery disease</td><td>No: 93 (95.9%)<br>Yes: 4 (4.1%)</td><td>No: 19 (100.0%)<br>Yes: 0 (0.0%)</td><td>0.00 (0.00-nan)</td><td>1.000</td></tr>
    <tr><td>Cirrhosis</td><td>No: 95 (97.9%)<br>Yes: 2 (2.1%)</td><td>No: 19 (100.0%)<br>Yes: 0 (0.0%)</td><td>0.00 (0.00-nan)</td><td>1.000</td></tr>
    <tr><td>Connective tissue disease</td><td>No: 96 (99.0%)<br>Yes: 1 (1.0%)</td><td>No: 19 (100.0%)<br>Yes: 0 (0.0%)</td><td>0.00 (0.00-nan)</td><td>1.000</td></tr>
    <tr><td>Chronic lung disease</td><td>No: 94 (96.9%)<br>Yes: 3 (3.1%)</td><td>No: 19 (100.0%)<br>Yes: 0 (0.0%)</td><td>0.00 (0.00-nan)</td><td>1.000</td></tr>
    <tr><td>Atrial fibrillation </td><td>No: 95 (97.9%)<br>Yes: 2 (2.1%)</td><td>No: 19 (100.0%)<br>Yes: 0 (0.0%)</td><td>0.00 (0.00-nan)</td><td>1.000</td></tr>
    <tr><td>Active malignancy </td><td>No: 57 (58.8%)<br>Yes: 40 (41.2%)</td><td>No: 7 (36.8%)<br>Yes: 12 (63.2%)</td><td>2.44 (0.84-7.23)</td><td>0.081</td></tr>
    <tr><td>Underlying disease</td><td>>= 1 medical disease: 64 (66.0%)<br>none: 33 (34.0%)</td><td>>= 1 medical disease: 14 (73.7%)<br>none: 5 (26.3%)</td><td>-</td><td>0.597</td></tr>
    <tr><td>Immobilization</td><td>No: 62 (63.9%)<br>Yes: 35 (36.1%)</td><td>No: 13 (68.4%)<br>Yes: 6 (31.6%)</td><td>0.82 (0.26-2.43)</td><td>0.796</td></tr>
    <tr><td>History of Deep vein thrombosis</td><td>N: 1 (1.0%)<br>No: 92 (94.8%)<br>Yes: 4 (4.1%)</td><td>No: 19 (100.0%)</td><td>-</td><td>1.000</td></tr>
    <tr><td>ocp</td><td>0: 92 (94.8%)<br>1: 5 (5.2%)</td><td>0: 17 (89.5%)<br>1: 2 (10.5%)</td><td>2.16 (0.32-11.41)</td><td>0.327</td></tr>
    <tr><td>smoking</td><td>0: 90 (92.8%)<br>1: 7 (7.2%)</td><td>0: 18 (94.7%)<br>1: 1 (5.3%)</td><td>0.71 (0.05-5.32)</td><td>1.000</td></tr>
    <tr><td>sx</td><td>0: 46 (47.4%)<br>1: 51 (52.6%)</td><td>0: 7 (36.8%)<br>1: 12 (63.2%)</td><td>1.54 (0.52-4.66)</td><td>0.435</td></tr>
    <tr><td>trauma</td><td>0: 89 (91.8%)<br>1: 8 (8.2%)</td><td>0: 16 (84.2%)<br>1: 3 (15.8%)</td><td>2.09 (0.42-8.79)</td><td>0.375</td></tr>

    <tr class="category-header"><td colspan="5">Clinical Presentation</td></tr>
    <tr><td>desat</td><td>0.0: 30 (30.9%)<br>1.0: 67 (69.1%)</td><td>0.0: 2 (10.5%)<br>1.0: 17 (89.5%)</td><td>3.81 (0.75-26.68)</td><td>0.088</td></tr>
    <tr><td>dyspnea_rest</td><td>0.0: 36 (37.1%)<br>1.0: 61 (62.9%)</td><td>0.0: 7 (36.8%)<br>1.0: 12 (63.2%)</td><td>1.01 (0.34-2.96)</td><td>1.000</td></tr>
    <tr><td>dyspnea_exertion</td><td>0.0: 26 (26.8%)<br>1.0: 71 (73.2%)</td><td>0.0: 5 (26.3%)<br>1.0: 14 (73.7%)</td><td>1.02 (0.31-3.66)</td><td>1.000</td></tr>
    <tr><td>cough</td><td>0.0: 85 (87.6%)<br>1.0: 12 (12.4%)</td><td>0.0: 15 (78.9%)<br>1.0: 4 (21.1%)</td><td>1.89 (0.46-7.14)</td><td>0.273</td></tr>
    <tr><td>syncope</td><td>0.0: 89 (91.8%)<br>1.0: 8 (8.2%)</td><td>0.0: 18 (94.7%)<br>1.0: 1 (5.3%)</td><td>0.62 (0.04-4.88)</td><td>1.000</td></tr>
    <tr><td>chestpain</td><td>0.0: 78 (80.4%)<br>1.0: 19 (19.6%)</td><td>0.0: 16 (84.2%)<br>1.0: 3 (15.8%)</td><td>0.77 (0.16-3.08)</td><td>1.000</td></tr>
    <tr><td>edema</td><td>0.0: 55 (56.7%)<br>1.0: 42 (43.3%)</td><td>0.0: 11 (57.9%)<br>1.0: 8 (42.1%)</td><td>0.95 (0.33-2.73)</td><td>1.000</td></tr>
    <tr><td>palpitation</td><td>0.0: 92 (94.8%)<br>1.0: 5 (5.2%)</td><td>0.0: 19 (100.0%)<br>1.0: 0 (0.0%)</td><td>0.00 (0.00-nan)</td><td>1.000</td></tr>
    <tr><td>fever</td><td>0.0: 92 (94.8%)<br>1.0: 5 (5.2%)</td><td>0.0: 17 (89.5%)<br>1.0: 2 (10.5%)</td><td>2.16 (0.32-11.41)</td><td>0.327</td></tr>
    <tr><td>resp</td><td>0.0: 84 (86.6%)<br>1.0: 13 (13.4%)</td><td>0.0: 12 (63.2%)<br>1.0: 7 (36.8%)</td><td>3.77 (1.17-11.95)</td><td>0.016</td></tr>

    <tr class="category-header"><td colspan="5">Physical Examination</td></tr>
    <tr><td>Body temperature</td><td>36.86 ± 0.48<br>Median: 37.00 (IQR: 0.40)</td><td>37.02 ± 0.59<br>Median: 37.00 (IQR: 0.30)</td><td>-</td><td>0.216</td></tr>
    <tr><td>Systolic BP (mmHg)</td><td>131.08 ± 19.04<br>Median: 131.00 (IQR: 26.00)</td><td>116.05 ± 17.70<br>Median: 110.00 (IQR: 16.00)</td><td>-</td><td><0.001</td></tr>
    <tr><td>Diastolic BP (mmHg)</td><td>81.94 ± 14.33<br>Median: 80.00 (IQR: 16.00)</td><td>72.11 ± 18.24<br>Median: 74.00 (IQR: 20.00)</td><td>-</td><td>0.028</td></tr>
    <tr><td>Heart Rate (bpm)</td><td>102.57 ± 20.87<br>Median: 105.00 (IQR: 24.00)</td><td>109.79 ± 19.69<br>Median: 113.00 (IQR: 21.00)</td><td>-</td><td>0.089</td></tr>
    <tr><td>Respiratory Rate (min)</td><td>22.82 ± 4.81<br>Median: 22.00 (IQR: 4.00)</td><td>25.32 ± 4.14<br>Median: 24.00 (IQR: 7.00)</td><td>-</td><td>0.007</td></tr>
    <tr><td>Oxygen Saturation (%)</td><td>91.36 ± 6.70<br>Median: 92.00 (IQR: 7.00)</td><td>89.26 ± 5.31<br>Median: 88.00 (IQR: 7.00)</td><td>-</td><td>0.033</td></tr>
    <tr><td>jvd</td><td>0.0: 92 (94.8%)<br>1.0: 5 (5.2%)</td><td>0.0: 18 (94.7%)<br>1.0: 1 (5.3%)</td><td>1.02 (0.06-9.74)</td><td>1.000</td></tr>
    <tr><td>leg_edema</td><td>0.0: 59 (60.8%)<br>1.0: 38 (39.2%)</td><td>0.0: 13 (68.4%)<br>1.0: 6 (31.6%)</td><td>0.72 (0.24-2.09)</td><td>0.605</td></tr>

    <tr class="category-header"><td colspan="5">Laboratory Data</td></tr>
    <tr><td>Arterial pH</td><td>7.44 ± 0.07<br>Median: 7.45 (IQR: 0.07)</td><td>7.43 ± 0.07<br>Median: 7.45 (IQR: 0.06)</td><td>-</td><td>0.796</td></tr>
    <tr><td>PaO2 (mmHg)</td><td>84.27 ± 38.53<br>Median: 71.85 (IQR: 27.95)</td><td>73.01 ± 19.75<br>Median: 69.30 (IQR: 21.50)</td><td>-</td><td>0.585</td></tr>
    <tr><td>pfratio</td><td>285.08 ± 77.95<br>Median: 282.85 (IQR: 75.75)</td><td>240.84 ± 110.01<br>Median: 258.00 (IQR: 164.25)</td><td>-</td><td>0.195</td></tr>
    <tr><td>PaCO2 (mmHg)</td><td>33.15 ± 7.97<br>Median: 32.50 (IQR: 8.65)</td><td>31.42 ± 9.39<br>Median: 30.10 (IQR: 13.00)</td><td>-</td><td>0.589</td></tr>
    <tr><td>Lactate (mmol/L)</td><td>2.12 ± 1.63<br>Median: 1.50 (IQR: 1.25)</td><td>3.68 ± 3.42<br>Median: 2.40 (IQR: 3.00)</td><td>-</td><td>0.063</td></tr>
    <tr><td>hb</td><td>12.02 ± 2.22<br>Median: 12.00 (IQR: 3.10)</td><td>11.45 ± 2.48<br>Median: 11.50 (IQR: 4.10)</td><td>-</td><td>0.435</td></tr>
    <tr><td>hct</td><td>36.56 ± 6.64<br>Median: 36.80 (IQR: 9.30)</td><td>34.46 ± 7.93<br>Median: 33.60 (IQR: 13.00)</td><td>-</td><td>0.245</td></tr>
    <tr><td>plt</td><td>253.90 ± 119.26<br>Median: 247.00 (IQR: 131.00)</td><td>224.22 ± 113.84<br>Median: 204.00 (IQR: 181.50)</td><td>-</td><td>0.364</td></tr>
    <tr><td>cr</td><td>1.30 ± 1.26<br>Median: 0.90 (IQR: 0.60)</td><td>1.79 ± 1.54<br>Median: 1.28 (IQR: 1.39)</td><td>-</td><td>0.082</td></tr>
    <tr><td>bicarb</td><td>22.25 ± 4.54<br>Median: 22.85 (IQR: 5.00)</td><td>20.65 ± 5.62<br>Median: 22.00 (IQR: 7.70)</td><td>-</td><td>0.316</td></tr>
    <tr><td>alb</td><td>3.32 ± 0.66<br>Median: 3.40 (IQR: 0.90)</td><td>3.13 ± 0.61<br>Median: 3.10 (IQR: 0.85)</td><td>-</td><td>0.306</td></tr>
    <tr><td>pt</td><td>14.88 ± 5.56<br>Median: 12.90 (IQR: 2.15)</td><td>15.82 ± 4.39<br>Median: 14.40 (IQR: 4.60)</td><td>-</td><td>0.177</td></tr>
    <tr><td>ptt</td><td>32.09 ± 15.69<br>Median: 26.65 (IQR: 7.00)</td><td>35.12 ± 13.37<br>Median: 31.50 (IQR: 18.05)</td><td>-</td><td>0.144</td></tr>
    <tr><td>inr</td><td>1.36 ± 0.66<br>Median: 1.15 (IQR: 0.17)</td><td>1.54 ± 0.72<br>Median: 1.28 (IQR: 0.64)</td><td>-</td><td>0.086</td></tr>
    <tr><td>Troponin</td><td>133.09 ± 372.48<br>Median: 21.65 (IQR: 70.88)</td><td>675.31 ± 1406.82<br>Median: 104.50 (IQR: 331.00)</td><td>-</td><td>0.126</td></tr>
    <tr><td>BNP</td><td>3226.79 ± 6032.22<br>Median: 1039.00 (IQR: 2899.75)</td><td>2573.71 ± 2548.53<br>Median: 1475.00 (IQR: 4235.00)</td><td>-</td><td>0.435</td></tr>
    <tr><td>D-Dimer</td><td>5960.67 ± 6614.99<br>Median: 3450.00 (IQR: 4224.00)</td><td>8309.80 ± 9706.74<br>Median: 4780.00 (IQR: 10600.00)</td><td>-</td><td>0.679</td></tr>

    <tr class="category-header"><td colspan="5">Investigations (ECG/CT/Echo)</td></tr>
    <tr><td>sinus</td><td>0: 45 (46.4%)<br>1: 52 (53.6%)</td><td>0: 7 (36.8%)<br>1: 12 (63.2%)</td><td>1.48 (0.50-4.49)</td><td>0.463</td></tr>
    <tr><td>rate</td><td>1: 22 (22.7%)<br>2: 75 (77.3%)</td><td>1: 3 (15.8%)<br>2: 16 (84.2%)</td><td>-</td><td>0.760</td></tr>
    <tr><td>s1q3t3</td><td>0: 67 (69.1%)<br>1: 30 (30.9%)</td><td>0: 15 (78.9%)<br>1: 4 (21.1%)</td><td>0.60 (0.15-2.02)</td><td>0.423</td></tr>
    <tr><td>rvstrain_EKG</td><td>0: 76 (78.4%)<br>1: 21 (21.6%)</td><td>0: 12 (63.2%)<br>1: 7 (36.8%)</td><td>2.11 (0.64-6.66)</td><td>0.151</td></tr>
    <tr><td>rbbb</td><td>0: 84 (86.6%)<br>1: 13 (13.4%)</td><td>0: 15 (78.9%)<br>1: 4 (21.1%)</td><td>1.72 (0.42-6.19)</td><td>0.464</td></tr>
    <tr><td>cardiomegaly </td><td>0: 38 (39.2%)<br>1: 59 (60.8%)</td><td>0: 6 (31.6%)<br>1: 13 (68.4%)</td><td>1.39 (0.46-4.57)</td><td>0.605</td></tr>
    <tr><td>trunk</td><td>0: 44 (45.4%)<br>1: 53 (54.6%)</td><td>0: 9 (47.4%)<br>1: 10 (52.6%)</td><td>0.92 (0.33-2.61)</td><td>0.871</td></tr>
    <tr><td>lung_investigate</td><td>0: 83 (85.6%)<br>1: 14 (14.4%)</td><td>0: 18 (94.7%)<br>1: 1 (5.3%)</td><td>0.33 (0.02-2.73)</td><td>0.457</td></tr>
    <tr><td>effusion</td><td>0: 71 (73.2%)<br>1: 26 (26.8%)</td><td>0: 12 (63.2%)<br>1: 7 (36.8%)</td><td>1.59 (0.52-4.70)</td><td>0.419</td></tr>
    <tr><td>prox_clot</td><td>0: 65 (67.0%)<br>1: 32 (33.0%)</td><td>0: 9 (47.4%)<br>1: 10 (52.6%)</td><td>2.26 (0.80-6.31)</td><td>0.126</td></tr>
    <tr><td>rvstrain_CT</td><td>0: 30 (30.9%)<br>1: 67 (69.1%)</td><td>0: 2 (10.5%)<br>1: 17 (89.5%)</td><td>3.81 (0.75-26.68)</td><td>0.088</td></tr>
    <tr><td>rvdilate</td><td>0.0: 30 (30.9%)<br>1.0: 32 (33.0%)<br>2.0: 17 (17.5%)<br>3.0: 18 (18.6%)</td><td>0.0: 3 (15.8%)<br>1.0: 6 (31.6%)<br>2.0: 4 (21.1%)<br>3.0: 6 (31.6%)</td><td>-</td><td>0.465</td></tr>
    <tr><td>rvfunction</td><td>0.0: 62 (63.9%)<br>1.0: 13 (13.4%)<br>2.0: 11 (11.3%)<br>3.0: 11 (11.3%)</td><td>0.0: 9 (47.4%)<br>1.0: 4 (21.1%)<br>2.0: 4 (21.1%)<br>3.0: 2 (10.5%)</td><td>-</td><td>0.548</td></tr>
    <tr><td>tapse</td><td>1.0: 15 (15.5%)<br>2.0: 22 (22.7%)<br>3.0: 10 (10.3%)<br>nan: 50 (51.5%)</td><td>1.0: 7 (36.8%)<br>2.0: 2 (10.5%)<br>3.0: 2 (10.5%)<br>nan: 8 (42.1%)</td><td>-</td><td>0.092</td></tr>
    <tr><td>pulmonaryht</td><td>0.0: 45 (46.4%)<br>1.0: 24 (24.7%)<br>2.0: 23 (23.7%)<br>3.0: 5 (5.2%)</td><td>0.0: 6 (31.6%)<br>1.0: 5 (26.3%)<br>2.0: 6 (31.6%)<br>3.0: 2 (10.5%)</td><td>-</td><td>0.669</td></tr>
    <tr><td>tvr</td><td>0.0: 65 (67.0%)<br>1.0: 2 (2.1%)<br>2.0: 30 (30.9%)</td><td>0.0: 12 (63.2%)<br>1.0: 1 (5.3%)<br>2.0: 6 (31.6%)</td><td>-</td><td>0.627</td></tr>
    <tr><td>lvfunction</td><td>0: 92 (94.8%)<br>1: 5 (5.2%)</td><td>0: 18 (94.7%)<br>1: 1 (5.3%)</td><td>1.02 (0.06-9.74)</td><td>1.000</td></tr>
    <tr><td>dvt_investigate</td><td>0.0: 40 (41.2%)<br>1.0: 24 (24.7%)<br>nan: 33 (34.0%)</td><td>0.0: 5 (26.3%)<br>1.0: 9 (47.4%)<br>nan: 5 (26.3%)</td><td>-</td><td>0.126</td></tr>

    <tr class="category-header"><td colspan="5">Management</td></tr>
    <tr><td>anticoag</td><td>1: 51 (52.6%)<br>2: 46 (47.4%)</td><td>1: 9 (47.4%)<br>2: 10 (52.6%)</td><td>-</td><td>0.672</td></tr>
    <tr><td>LMWH</td><td>0: 47 (48.5%)<br>1: 50 (51.5%)</td><td>0: 10 (52.6%)<br>1: 9 (47.4%)</td><td>0.85 (0.30-2.39)</td><td>0.796</td></tr>
    <tr><td>UFH</td><td>0: 50 (51.5%)<br>1: 47 (48.5%)</td><td>0: 9 (47.4%)<br>1: 10 (52.6%)</td><td>1.18 (0.42-3.32)</td><td>0.796</td></tr>
    <tr><td>reperfusion</td><td>0: 64 (66.0%)<br>1: 33 (34.0%)</td><td>0: 10 (52.6%)<br>1: 9 (47.4%)</td><td>1.75 (0.61-4.99)</td><td>0.297</td></tr>
    <tr><td>catheter-based fibrinolysis</td><td>0: 76 (78.4%)<br>1: 21 (21.6%)</td><td>0: 12 (63.2%)<br>1: 7 (36.8%)</td><td>2.11 (0.64-6.66)</td><td>0.151</td></tr>
    <tr><td>systemic fibrinolysis</td><td>0: 84 (86.6%)<br>1: 13 (13.4%)</td><td>0: 15 (78.9%)<br>1: 4 (21.1%)</td><td>1.72 (0.42-6.19)</td><td>0.464</td></tr>
    <tr><td>surgical embolectomy</td><td>0: 96 (99.0%)<br>1: 1 (1.0%)</td><td>0: 18 (94.7%)<br>1: 1 (5.3%)</td><td>5.33 (0.13-289.87)</td><td>0.304</td></tr>
    <tr><td>vent</td><td>0: 62 (63.9%)<br>1: 29 (29.9%)<br>2: 4 (4.1%)<br>3: 1 (1.0%)<br>4: 1 (1.0%)</td><td>0: 3 (15.8%)<br>1: 5 (26.3%)<br>2: 3 (15.8%)<br>3: 1 (5.3%)<br>4: 7 (36.8%)</td><td>-</td><td><0.001</td></tr>
    <tr><td>oxygen canula</td><td>0: 52 (53.6%)<br>1: 45 (46.4%)</td><td>0: 13 (68.4%)<br>1: 6 (31.6%)</td><td>0.53 (0.17-1.57)</td><td>0.231</td></tr>
    <tr><td>mask with bag</td><td>0: 93 (95.9%)<br>1: 4 (4.1%)</td><td>0: 15 (78.9%)<br>1: 4 (21.1%)</td><td>6.20 (1.18-35.09)</td><td>0.019</td></tr>
    <tr><td>High flow nasal canula</td><td>0: 97 (100.0%)</td><td>0: 18 (94.7%)<br>1: 1 (5.3%)</td><td>-</td><td>0.164</td></tr>
    <tr><td>endotracheal tube</td><td>0: 96 (99.0%)<br>1: 1 (1.0%)</td><td>0: 12 (63.2%)<br>1: 7 (36.8%)</td><td>56.00 (6.10-1498.05)</td><td><0.001</td></tr>

    <tr class="category-header"><td colspan="5">Secondary Outcomes</td></tr>
    <tr><td>mortality_pe</td><td>0: 97 (100.0%)</td><td>1: 15 (78.9%)<br>nan: 4 (21.1%)</td><td>-</td><td><0.001</td></tr>
    <tr><td>mortality_nonpe</td><td>0: 97 (100.0%)</td><td>1: 1 (5.3%)<br>2: 1 (5.3%)<br>3: 1 (5.3%)<br>4: 1 (5.3%)<br>nan: 15 (78.9%)</td><td>-</td><td><0.001</td></tr>
    <tr><td>arrest</td><td>0: 97 (100.0%)</td><td>1: 2 (10.5%)<br>2: 17 (89.5%)</td><td>-</td><td><0.001</td></tr>
    <tr><td>rvdilate_outcome</td><td>0.0: 24 (24.7%)<br>1.0: 20 (20.6%)<br>2.0: 5 (5.2%)<br>3.0: 6 (6.2%)<br>nan: 42 (43.3%)</td><td>2.0: 1 (5.3%)<br>nan: 18 (94.7%)</td><td>-</td><td>0.038</td></tr>
    <tr><td>Rv correct</td><td>0.0: 25 (25.8%)<br>1.0: 30 (30.9%)<br>nan: 42 (43.3%)</td><td>1.0: 1 (5.3%)<br>nan: 18 (94.7%)</td><td>-</td><td>0.021</td></tr>
    <tr><td>rvfunction_outcome</td><td>0.0: 36 (37.1%)<br>1.0: 11 (11.3%)<br>2.0: 8 (8.2%)<br>nan: 42 (43.3%)</td><td>2.0: 1 (5.3%)<br>nan: 18 (94.7%)</td><td>-</td><td>0.027</td></tr>
    <tr><td>tapse_outcome</td><td>0.0: 30 (30.9%)<br>1.0: 25 (25.8%)<br>nan: 42 (43.3%)</td><td>1.0: 1 (5.3%)<br>nan: 18 (94.7%)</td><td>-</td><td>0.013</td></tr>
    <tr><td>pulmonaryht_outcome</td><td>0.0: 27 (27.8%)<br>2.0: 21 (21.6%)<br>3.0: 7 (7.2%)<br>nan: 42 (43.3%)</td><td>2.0: 1 (5.3%)<br>nan: 18 (94.7%)</td><td>-</td><td>0.032</td></tr>
    <tr><td>tvr_outcome</td><td>0.0: 13 (13.4%)<br>1.0: 22 (22.7%)<br>2.0: 20 (20.6%)<br>nan: 42 (43.3%)</td><td>2.0: 1 (5.3%)<br>nan: 18 (94.7%)</td><td>-</td><td>0.027</td></tr>
    <tr><td>lvfunction_outcome</td><td>0.0: 52 (53.6%)<br>1.0: 3 (3.1%)<br>nan: 42 (43.3%)</td><td>1.0: 1 (5.3%)<br>nan: 18 (94.7%)</td><td>-</td><td>0.014</td></tr>

  </tbody>
</table>

</body>
</html>
